Antifungal activity of macrophages engineered to produce IFNγ: Inducibility by picolinic acid

Medical Microbiology and Immunology

Volumn 192, Issue 2, 2003, Pages 71-78

  Mucci, Anna ^a   Varesio, Luigi ^b   Neglia, Rachele ^a   Colombari, Bruna ^a   Pastorino, Sandra ^b   Blasi, Elisabetta ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

Antifungal activity; Engineered macrophages; Interferon ; Picolinic acid

Indexed keywords

GAMMA INTERFERON; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PICOLINIC ACID;

ANTIFUNGAL ACTIVITY; ARTICLE; CELL LINE; COCULTURE; CYTOKINE PRODUCTION; DNA VECTOR; GENE EXPRESSION; GENETIC ENGINEERING; MACROPHAGE; MICROGLIA; MYCOSIS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TIME;

EID: 0038807871     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-002-0118-1     Document Type: Article

References (53)

1. Barluzzi R, Brozzetti A, Delfino D, Bistoni F, Blasi E (1998) Role of the capsule in microglial cell-Cryptococcus neoformans interaction: impairment of antifungal activity but not secretory functions. Med Mycol 36:189-197
2. Blasi E, Radzioch D, Varesio L (1988) Inhibition of retroviral mRNA expression in the murine macrophage cell line GG2EE by biological response modifiers. J Immunol 141:2153-2157
3. Blasi E, Barluzzi R, Bocchini V, Mazzolla R, Bistoni F (1990) Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J Neuroimmunol 27:229-237
4. Blasi E, Mazzolla R, Barluzzi R, Mosci P, Bartoli A, Bistoni F (1991) Intracerebral transfer of an in vitro established microglial cell line: local induction of a protective state against lethal challenge with Candida albicans. J Neuroimmunol 32:249-257
5. Blasi E, Pitzurra L, Puliti M, Lanfrancone L, Bistoni F (1992) Early differential molecular response of macrophage cell line to yeast and hyphal forms of Candida albicans. Infect Immun 60:832-837
6. Blasi E, Mazzolla R, Pitzurra L, Barluzzi R, Bistoni F (1993) Protective effect of picolinic acid on mice intracerebrally infected with lethal doses of Candida albicans. Antimicrob Agents Chemother 37:2422-2426
7. Blasi E, Barluzzi R, Mazzolla R, Tancini B, Saleppico S, Puliti M, Pitzurra L, Bistoni F (1995) Role of nitric oxide and melanogenesis in the accomplishment of anticryptococcal activity the BV-2 microglial cell line. J Neuroimmunol 58:111-116
8. Blasi E, Pitzurra L, Puliti M, Chimienti AR, Mazzolla R, Barluzzi R, Bistoni F (1995) Differential susceptibility of yeast and hyphal forms of Candida albicans to macrophage-derived nitrogen-containing compounds. Infect Immun 63:1806-1809
9. Blasi E, Brozzetti A, Francisi D, Neglia R, Cardinali G, Bistoni F, Vidotto V, Baldelli F (2001) Evidence of microevolution in a clinical case of recurrent Cryptococcus neoformans meningoencephalitis. Eur J Clin Microbiol Infect Dis 20:535-543
10. Carta L, Pastorino S, Melillo G, Bosco MC, Massazza S, Varesio L (2001) Engineering of macrophages to produce IFN-γ in response to hypoxia. J Immunol 166:5377-5380
11. Dazzi C, Candiano G, Massazza S, Ponzetto A, Varesio L (2001) New high-performance liquid chromatographic method for the detection of picolinic acid in biological fluids. J Chromatogr B Biomed Appl 751:61-68
12. Drapier JC, Wietzerbin J, Hibbs JB Jr (1988) Interferon-γ and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur J Immunol 18:1587-1592
13. Feldmesser M, Kress Y, Novikoff P, Casadevall A (2000) Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect Immun 68:4225-4237
14. Feldmesser M, Tucker S, Casadevall A (2001) Intracellular parasitism of macrophages by Cryptococcus neoformans. Trends Microbiol 9:273-278
15. Franzot SP, Mukherjee J, Cherniak R, Chen LC, Hadman JS, Casadevall A (1998) Microevolution of a standard strain of Cryptococcus neoformans resulting in a differences in virulence and other phenotypes. Infect Immun 66:89-97
16. Garcia-Hermoso D, Janbon G, Dromer F (1999) Epidemiological evidence for dormant Cryptococcus neoformans infection. J Clin Microbiol 37:3204-3209
17. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, Giaccia AJ (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature 379:88-91
18. Griffiths L, Binley K, Iqball S, Kan O, Maxwell P, Ratcliffe P, Lewis C, Harris A, Kingsman S, Naylor S (2000) The macrophage-a novel system to deliver gene therapy to pathological hypoxia. Gene Ther 7:255-262
19. Guyre PM, Morganelli PM, Miller R (1983) Recombinant immune interferon increases immunoglobulin G Fc receptors on cultured human mononuclear phagocytes. J Clin Invest 72:393-397
20. Hahn H, Kaufmann SHE (1981) The role of cell-mediated immunity in bacterial infections. Rev Infect Dis 3:1221-1250
21. Jungi TW, Lerch PG, Breic M (1987) The effect of recombinant interferon-γ on human monocyte-derived macrophages. Eur J Immunol 17:735-738
22. Káposzta R, Tree P, Maródi L, Gordon S (1998) Characteristics of invasive candidiasis in gamma interferon- and interleukin-4-deficient mice: role of macrophages in host defense against Candida albicans. Infect Immun 66:1708-1717
23. Káposzta R, Maródi L, Hollinshead M, Gordon S, Silva RP da (1999) Rapid recruitment of late endosomes and lysosomes in mouse macrophages ingesting Candida albicans. J Cell Sci 112:3237-3248
24. Kozel TR, Pfrommer GS, Guerlain AS, Highison BA, Highison GJ (1988) Role of the capsule in phagocytosis of Cryptococcus neoformans. Rev Infect Dis 10:436-439
25. Kulberg BJ, Van't Wout JW, Hoogstraten C, Furth R van (1993) Recombinant interferon-γ enhances resistance to acute disseminated Candida albicans infection in mice. J Infect Dis 168:436-443
26. Kurzrock R, Rosenblum MG, Sherwin SA, Rios A, Talpaz M, Quesada JR, Gutterman JU (1985) Pharmacokinetics, single-dose tolerance, and biological activity of recombinant gamma-intrferon in cancer patients. Cancer Res 45: 2866-2872
27. Langermans JA, Hazenbons WL, van Furth R (1994) Antimicrobial functions of mononuclear phagocytes. J Immunol Methods 174):185-194
28. Lewis JS, Lee JA, Underwood JCE, Harris AL, Lewis CE (1999) Macrophage responses to hypoxia: relevance to disease mechanisms. J Leukoc Biol 66:889-900
29. Marodi L, Forehand JR, Johnston RB Jr (1991) Mechanisms of host defense against Candida species. II. Biochemical basis for the killing of Candida by mononuclear phagocytes. J Immunol 146:2790-2794
30. Marodi L, Korchak HM, Johnston RB Jr (1991) Mechanisms of host defense against Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages. J Immunol 146:2783-2789
31. Maxwell PH, Dachs GU, Gleadle JM, Nicholls LG, Harris AL, Stratford IJ, Hankinson O, Pugh CW, Ratcliffe PJ (1997) Hypoxia inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA 94:8104-8109
32. Melillo G, Cox GW, Radzioch D, Varesio L (1993) Picolinic acid, a catabolite of L-tryptophan, is a costimulus for the induction of reactive nitrogen intermediate production in murine macrophages. J Immunol 150:4031-4040
33. Melillo G, Cox GW, Biragyn A, Sheffler LA, Varesio L (1994) Regulation of nitric-oxide synthase mRNA expression by interferon-γ and picolinic acid. J Biol Chem 269:8128-8133
34. Melillo G, Taylor LS, Brooks A, Musso T, Cox GW, Varesio L (1997) Functional requirement of the hypoxia-responsive element in the activation of the inducible niric oxide synthase promoter by the iron chelator desferrioxamine. J Biol Chem 272:12236-12243
35. Moulder JW (1985) Comparative biology of intracellular parasitism. Microbiol Rev 49:298-337
36. Nathan CF (1987) Secretory products of macrophages. J Clin Invest 79:319-326
37. Odds FC (1985) Morphogenesis in Candida albicans. Crit Rev Microbiol 12(1):45-93
38. Pais TF, Appelberg R (2000) Macrophage control of mycobacterial growth induced by picolinic acid is dependent on host cell apoptosis. J Immunol 164:389-397
39. Perfect JR, Wong B, Chang YC, Known-Chung KJ, Williamson PR (1998) Cryptococcus neoformans: virulence and host defenses. Med Mycol Rev 36:79-86
40. Ratcliffe PJ, O'Rourke JF, Maxwell PH, Pugh CW (1998) Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. J Exp Biol 201:1153-1162
41. Rathman M, Sjaastad MD, Falkow S (1996) Acidification of phagosomes containing Salmonella typhimurium in murine macrophages. Infect Immun 64:2765-2773
42. Ruffman R, Welker RD, Saito T, Chirigos MA, Varesio L (1984) In vivo activation of macrophages but not natural killer cells by picolinic acid (PLA). J Immunopharmacol 6:291-304
43. Russell DG (1994) Immunoelectron microscopy of endosomal trafficking in macrophages infected with microbial pathogens. Methods Cell Biol 45:277-288
44. Semenza GL (2000) Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol 35:71-103
45. Tardieux I, Webster P, Ravesloot J, Boron W, Lunn JA, Heuser JE, Andrews NW (1992) Lysosome recruitment and fusion are early events required for Trypanosoma invasion of mammalian cells. Cell 71:1117-1130
46. Van't Wout JW, Meynaar I, Linde I, Poell R, Mattie H, Van Furth R (1990) Effect of amphotericin B, fluconazole and itraconazole on the number of intracellular Candida albicans and development of germ tubes in macrophages. J Antimicrob Chemother 25:803-811
47. Váquez-Torres A, Balish E (1997) Macrophages in resistance to candidiasis. Microbiol Mol Biol Rev 61:170-192
48. Varesio L (1985) Imbalanced accumulation of ribosomal RNA in macrophages activated in vivo or in vitro to a cytolitic stage. J Immunol 134:1262-1267
49. Varesio L, Clayton M, Blasi E, Ruffman R, Radzioch D (1990) Picolinic acid, a catabolite of tryptophan, as the second signal in the activation of IFNγ-primed macrophages. J Immunol 145:4265-4271
50. Wang GL, Semenza GL (1993) Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82:3610-3615
51. Wojciechowski W, DeSanctis J, Skamene E, Radzioch D (1999) Attenuation of MHC class II expression in macrophages infected with Mvcobacterium boris Bacillus Calmette-Guerin involves class II transactivator and depends on the Nrampl gene. J Immunol 163:2688-2696
52. Wu M, Hussain S, He YH, Pasula R, Smith PA, Martin WJ 2nd (2001) Genetically engineered macrophages expressing IFNgamma restore alveolar immune function in scid mice. Proc Natl Acad Sci USA 98:14589-14594
53. Young HA, Hardy KJ (1995) Role of interferon-gamma in immune cell regulation. J Leukoc Biol 58:373-381